Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Pseudo Biologist who wrote (7310)	12/16/1999 12:01:00 PM
From: RCMac	Read Replies (2) \| Respond to of 9719

>>I have been corrected . . . Murphy did not have a buy on ISIP, and apparently had stopped following it for some time (or maybe never did, not clear). Either way, apologies to Murphy for blaming this particular dog on him.<< PB, the November 19, 1999 issue of Murphy's CTSL has the following about ISIP: "The stock moved up with the market to close near $15 yesterday. Complete your positions under our buy limit of $16 and tuck it away for the $125 target." My recollection is that both Murphy and McCamant have followed, and both have enthusiastically recommended, ISIP continuously for several years. --RCM